218 related articles for article (PubMed ID: 16005575)
41. [Computed tomographic determination of the target volume and the evaluation of remission after radiation of bronchial carcinoma].
Feyerabend T; Schmitt R; Richter E; Bohndorf W
Strahlenther Onkol; 1990 Jun; 166(6):405-10. PubMed ID: 2163548
[TBL] [Abstract][Full Text] [Related]
42. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
[TBL] [Abstract][Full Text] [Related]
43. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
[TBL] [Abstract][Full Text] [Related]
44. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
[TBL] [Abstract][Full Text] [Related]
45. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
[TBL] [Abstract][Full Text] [Related]
46. Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer.
Kupelian PA; Langen KM; Zeidan OA; Meeks SL; Willoughby TR; Wagner TH; Jeswani S; Ruchala KJ; Haimerl J; Olivera GH
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):876-82. PubMed ID: 17011460
[TBL] [Abstract][Full Text] [Related]
47. Localization accuracy of the clinical target volume during image-guided radiotherapy of lung cancer.
Hugo GD; Weiss E; Badawi A; Orton M
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):560-7. PubMed ID: 21277096
[TBL] [Abstract][Full Text] [Related]
48. Daily megavoltage computed tomography in lung cancer radiotherapy: correlation between volumetric changes and local outcome.
Bral S; De Ridder M; Duchateau M; Gevaert T; Engels B; Schallier D; Storme G
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1338-42. PubMed ID: 20638192
[TBL] [Abstract][Full Text] [Related]
49. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
[TBL] [Abstract][Full Text] [Related]
50. Utility of four-dimensional computed tomography for analysis of intrafractional and interfractional variation in lung volumes.
Rosen B; Starkschall G; Britton K; Mohan R; Cox JD
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):288-94. PubMed ID: 18722279
[TBL] [Abstract][Full Text] [Related]
51. Actual dose variation of parotid glands and spinal cord for nasopharyngeal cancer patients during radiotherapy.
Han C; Chen YJ; Liu A; Schultheiss TE; Wong JY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1256-62. PubMed ID: 18234431
[TBL] [Abstract][Full Text] [Related]
52. Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy.
Geets X; Tomsej M; Lee JA; Duprez T; Coche E; Cosnard G; Lonneux M; Grégoire V
Radiother Oncol; 2007 Oct; 85(1):105-15. PubMed ID: 17562346
[TBL] [Abstract][Full Text] [Related]
53. Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration.
Lee C; Langen KM; Lu W; Haimerl J; Schnarr E; Ruchala KJ; Olivera GH; Meeks SL; Kupelian PA; Shellenberger TD; Mañon RR
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1563-71. PubMed ID: 18538505
[TBL] [Abstract][Full Text] [Related]
54. Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy.
Song CH; Pyo H; Moon SH; Kim TH; Kim DW; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):651-8. PubMed ID: 20207499
[TBL] [Abstract][Full Text] [Related]
55. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
[TBL] [Abstract][Full Text] [Related]
56. Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: a prospective clinical study.
Bosmans G; van Baardwijk A; Dekker A; Ollers M; Boersma L; Minken A; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):748-53. PubMed ID: 17011450
[TBL] [Abstract][Full Text] [Related]
57. Dosimetric effect of respiratory motion in external beam radiotherapy of the lung.
Mechalakos J; Yorke E; Mageras GS; Hertanto A; Jackson A; Obcemea C; Rosenzweig K; Clifton Ling C
Radiother Oncol; 2004 May; 71(2):191-200. PubMed ID: 15110453
[TBL] [Abstract][Full Text] [Related]
58. [Scan acquisition parameter optimization for the treatment of moving tumors in radiotherapy].
Ayadi M; Bouilhol G; Imbert L; Ginestet C; Sarrut D
Cancer Radiother; 2011 Apr; 15(2):115-22. PubMed ID: 21112229
[TBL] [Abstract][Full Text] [Related]
59. Patient dose from megavoltage computed tomography imaging.
Shah AP; Langen KM; Ruchala KJ; Cox A; Kupelian PA; Meeks SL
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1579-87. PubMed ID: 18234438
[TBL] [Abstract][Full Text] [Related]
60. Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?
Berkovic P; Paelinck L; Lievens Y; Gulyban A; Goddeeris B; Derie C; Surmont V; De Neve W; Vandecasteele K
Acta Oncol; 2015; 54(9):1438-44. PubMed ID: 26405809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
